Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion type Assertion NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_head.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion evidence source_evidence_literature NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion SIO_000772 19861960 NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion wasDerivedFrom befree-2016 NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.
- NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_assertion wasGeneratedBy ECO_0000203 NP772129.RA69zjwDIx3F8G_LG3V39m3O114KUc9wInaWIUxYOY2Y0130_provenance.